Similar Posts
Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression
Ketamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.
‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU
NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.
Taking a Psychedelic Trip? There’s an App for That
There are apps for nearly everything, these days. Now, there’s…
Interested in Becoming a Magic Mushroom Trip Sitter?
Being a good trip sitter isn’t all that different from…
Atai is going PUBLIC! Company Rundown and MindMed Comparison
Powered by Restream https://restream.io/
What’s up Psychedelic Investors?!? We have some big news for you. Atai Life Sciences will be going public imminently, directly competing with companies like MindMed (MMED / MMEDF / MMQ) and Numinus (NUMI). This will be a catalyst for the entire sector, and I am excited.
I will be buying some atai when it goes public, how about you?
If you wish to collaborate, send us an email at:
thepsychedelicinvestor@gmail.com
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#AtaiLifeSciences #AtaiIPO #MindMed
The Stoned Ape Theory: Pseudoscience or Psychedelic Origin of Modern Man?
Did early humans accelerate evolution by tripping balls on psychedelic mushrooms? One psychonaut ethnobiologist says: absolutely.